Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Psoriasis × Folic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 16 Carcinoma, Non-Small-Cell Lung 12 Colorectal Neoplasms 10 Lung Neoplasms 8 Recurrence 5 Neoplasm Metastasis 5 Colonic Neoplasms 5 Rectal Neoplasms 4 Breast Neoplasms 4 Neoplasms 3 Lymphoma, T-Cell, Peripheral 3 Infertility 3 Urinary Bladder Neoplasms 2 Sezary Syndrome 2 Ovarian Neoplasms 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, T-Cell 2 Insulin Resistance 2 Infertility, Female 2 Hyperandrogenism 2 Head and Neck Neoplasms 2 Diabetes, Gestational 2 Carcinoma, Transitional Cell 2 Atypical Squamous Cells of the Cervix 2 Anovulation 2 Adenoma 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Ureteral Neoplasms 1

Interventions

tofacitinib 6 Etanercept 6 Methotrexate 4 Adalimumab 4 deucravacitinib 3 secukinumab 2 apremilast 2 Nivolumab 2 sotrastaurin 1 purine 1 fumaric acid 1 calcipotriene 1 baricitinib 1 Vitamin D 1 Sulfasalazine 1 Standard of Care 1 Specimen Handling 1 Practice Guidelines as Topic 1 Methods 1 Mesalamine 1 Mercaptopurine 1 Interviews as Topic 1 Infliximab 1 Folic Acid 1 Fish Oils 1 Fatty Acids, Omega-3 1 Exercise 1 Eicosapentaenoic Acid 1 Educational Status 1 Eating 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00932113 2017-08-31

MOA

Tufts Medical Center

Phase 4 Completed

33 enrolled 11 charts

Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡